Novartis’ Cholesterol Drug Inclisiran Closes In On EU Approval
Drug Will Be Known As Leqvio
Timing means full EU approval could coincide with US FDA authorization later this year.
Timing means full EU approval could coincide with US FDA authorization later this year.